# Development of a Molecular Diagnosing Platform for Monitoring Oral Hygiene in Diabetic Patients

> **NCT03351530** · — · UNKNOWN · sponsor: **General Biologicals Corporation** · enrollment: 120 (estimated)

## Conditions studied

- Diabetes Mellitus
- Periodontal Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03351530
- **Lead sponsor:** General Biologicals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-18
- **Primary completion:** 2018-12-09
- **Final completion:** 2019-02-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03351530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03351530, "Development of a Molecular Diagnosing Platform for Monitoring Oral Hygiene in Diabetic Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03351530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*